patients with coronary artery disease. Acute coronary thrombosis not resulting in myocardial infarction
Conditions
Interventions
Intervention 1: Control group: Propofol group: in this group we will infuse 50 µg/kg/min propofol in 6 hours (before the time of extubation ).The RASS will use to assess patients’ levels of sedatio
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: cardiovascular surgery aged above 18 years
Exclusion criteria
Exclusion criteria: If patients received both dexmedetomidine and propofol concomitantly for the primary sedation or an alternative agent as the primary sedation Prior solid organ transplant Pregnant patients Lactating patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of patient satisfaction with sedation during intubation. Timepoint: The drugs used will start after patients start to wake up, and 4-6 hours before the time of extubation in both groups .The Richmond Agitation and Sedation Scale (RASS) and Mary's Hospital Sleep Questionnaire used the day after operation in ICU. Method of measurement: The Richmond Agitation and Sedation Scale (RASS) and Mary's Hospital Sleep Questionnaire and vital sign and patients lab data. | — |
Secondary
| Measure | Time frame |
|---|---|
| The effect of sedation on analgesia after extubation. Timepoint: Based on the Richmond Agitation and Sedation Scale (RASS), and Mary's Hospital Sleep Questionnaire (SMHSQ)which is a valid and reliable method for assessing patient sedation in the intensive care unit. And completing the questionnaire the next day. Method of measurement: Richmond Agitation and Sedation Scale (RASS), and Mary's Hospital Sleep Questionnaire (SMHSQ) and completing a questionnaire on the duration of intubation and intensive care drugs like inoteropes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Ghadimi
Iran University of Medical Sciences
Outcome results
None listed